The two companies have set up a joint investment company which will invest a total of up to $100m in digital medicine startups.

Corporate-backed fund CapAgro participated in the early-stage round, which will support development of Olygose's nutrition technology.

Orphazyme has secured $24m in a Novo-backed round that will fund a clinical trial for its lead drug candidate, a treatment for a rare cholesterol-caused disease.

Tengelmann and Access-backed online shopping club Westwing has secured $29.7m from existing investors at a $529m valuation.

Nottingham University partners Tioga to develop heartrate monitoring technology for babies.

Simon Clark, who has also served as chairman of the BVCA, has left Fidelity's European venture capital unit after 15 years as managing partner.